The Indian diagnostics sector, an integral part of the nation’s healthcare system, is undergoing a remarkable transformation. It is characterised by its wide range of service providers and the varied quality of services offered. Valued at over $ 15B in the fiscal year 2024, it represents around 6 per cent of India’s overall healthcare market. The demand for diagnostics services is rising due to an ageing population, a growing middle class with higher disposable incomes, and an increasing burden of chronic diseases. Additionally, the COVID-19 pandemic has underscored the importance of timely and accurate diagnostics, further accelerating growth. With a projected CAGR of 14 per cent over the next five years, this sector is poised for significant expansion. The sector is also seeing a significant influx of investments, both from domestic and international players, eager to tap into the vast potential of this growing market
The Indian diagnostics market is dominated by pathology, contributing about 60 per cent of the sector’s revenue. This includes a wide range of tests, from clinical chemistry and immunology to haematology and specialised diagnostics. Pathology services are crucial for disease diagnosis, monitoring, and management, making them a cornerstone of the diagnostics industry
0 per cent of the diagnostics market, encompassing imaging techniques such as X-rays, CT scans, MRI, ultrasound, and nuclear imaging. Radiology plays a vital role in diagnosing a variety of conditions, from fractures and tumours to cardiovascular diseases and neurological disorders. The growth of the radiology segment is driven by technological advancements and growing disease complexity, enhancing diagnostic accuracy and efficiency. Additionally, the increasing prevalence of chronic diseases and a rising demand for early and accurate diagnosis are fueling the expansion of both pathology and radiology markets.
Key trends shaping the industry
As the Indian diagnostics sector continues to evolve, several key themes are set to define its future. These themes are poised to shape the trajectory of the industry, enhancing accessibility and ensuring that diagnostics services meet the ever-changing needs of the population. The digital revolution is a significant driver of growth in the Indian diagnostics landscape. The integration of digital solutions, such as tele-diagnostics and remote image reading, enhances the utilisation of expert resources and improves customer experiences through online booking systems and automated support. Digital transformation is streamlining operations, making diagnostic services more accessible and efficient. Alongside this, innovations in supply chain management, such as improved logistics and better inventory management, are reducing costs and enhancing service delivery. Streamlined operations ensure timely and accurate test results, which are essential for maintaining competitiveness and meeting growing demand.
Innovative business models are also transforming the diagnostics sector. Services such as home collection, subscription-based health packages, and direct-to-consumer testing are becoming increasingly popular. These models offer convenience and affordability, making it easier for patients to access diagnostic services.
The fragmented nature of the diagnostics market also presents ample opportunities for consolidation. Strategic mergers and acquisitions enable companies to scale up operations, enhance capabilities, and improve quality standards. The average EBITDA-multiple of these recent acquisitions have been in the range of 7x to 29x. Operating on a larger scale allows these chains to achieve cost savings, gain better negotiation power with suppliers, and invest in advanced technologies. This trend toward consolidation is expected to continue as companies strive to build stronger, more integrated networks.
The emergence of new clinical needs is driving the development of advanced diagnostic tests. Innovations in molecular diagnostics, genetic testing, and personalised medicine are addressing these emerging clinical needs. As new clinical needs emerge, the diagnostics sector continues to evolve, offering more sophisticated and targeted testing solutions. Additionally, health insurance penetration in India is underpenetrated as compared to developed countries. A rise in health insurance penetration can reduce the financial burden on patients and promote a proactive approach to health management.
Patient expectations are also evolving, with a growing demand for home collection services. These services cater to the patient’s need for convenience and efficiency, enhancing the overall patient.
experience. There is also significant growth potential in tier 2 and tier 3 cities, as well as rural areas, driven by rising healthcare awareness, improved infrastructure, and growing disposable incomes. Expanding into these regions allows diagnostics companies to tap into a large and underserved market, offering essential health services to a broader population. The industry is responding by offering faster turnaround times, home sample collection, and comprehensive wellness packages.
Finally, government initiatives and regulatory frameworks are playing a crucial role in shaping the diagnostics sector. Policies aimed at improving healthcare access, quality standards, and affordability are driving growth and ensuring compliance across the industry. Regulatory measures help maintain high service standards and ensure that diagnostic centres operate ethically and efficiently. Government labs are expected to grow at a CAGR of 12 per cent between 2023 and 2027, indicating significant opportunities, primarily through PPP models. The government’s support for the healthcare sector is essential for the continued growth and development of the diagnostics industry.
In conclusion, the Indian diagnostics sector is on an upward growth trajectory, supported by technological advancements, strategic consolidation, and evolving market dynamics. As the industry continues to innovate and expand, it is poised to play an increasingly vital role in the country’s healthcare ecosystem. The future of diagnostics in India looks promising, with the potential to significantly enhance the quality of healthcare and improve health outcomes for people across the country.